|Last Price$29.08||Day Change (%)0.41%|
|Open Price$29.08||Day Change ($)0.12|
|Day Range29.08–29.08||52-Week Range20.34–29.89|
As of Fri 01/20/2017 | USD
Palisades Hudson Newsletter: http://palisadeshudson.com/sentinel/ Larry Elkin's Blog: http://palisadeshudson.com/current-commentary/
Sokol's resignation clouds Berkshire's succession plan, while his Lubrizol trades tarnish to some extent the firm's legacy of strong ethical behavior.
Quarterly results were an improvement on prior-year earnings, though book value per share came in lower than we expected.
Berkshire's non-insurance operations continue to be an added source of stability while reinsurance operations continue to struggle.
2013 results once again demonstrate the value of Berkshire's diversified portfolio, as solid and consistent performance from the firm's non-insurance operations helped smooth out some of the volatility seen in its insurance businesses.
Alternative methods have some use, but we think discounted cash flow is the most fundamentally sound way to value the conglomerate, as we discuss in the final installment of our 5-part series.
Morningstar's Gregg Warren, who will be on the analyst panel at this year's meeting, details the questions he hopes Buffett and Munger will address.
Noninsurance operations continue to be a source of stability, while its insurance business overall may see more meager results during the next couple of years.
Just about every segment at Berkshire was dealing with elevated costs during the first quarter.
We'd like to see Buffett address future acquisitions, his take on the economy, the firm's succession plan, and more at this year's annual meeting.